US Patent 9238080 Bi-specific fusion proteins
Patent 9238080 was granted and assigned to Merrimack Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9238080 Bi-specific fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.